Subscribe To
Closing bell: bmo us put write hedged to cad etf down on wednesday (zph)
Detailed price information for BMO US Put Write Hedged To CAD ETF (ZPH-T) from The Globe and Mail including charting and trades. Read Full Story at so...
September 27, 2023, 10:44 pm
South korean automakers hyundai and kia are recalling 3.3 million vehicles in the us
That's A LOT of cars! Hyundai and Kia are recalling a combined 3.37 million vehicles in the United States due to the risk of engine fires:say that int...
September 27, 2023, 10:10 pm
Montgomery woman convicted on charges of federal loan fraud
MONTGOMERY, Ala. (WSFA) – A federal jury has convicted Montgomery woman Zsa Zsa Bouvier Couch on charges of fraud. She was indicted April 8, 2021 fo...
September 27, 2023, 9:59 pm
Eur/usd lingers near eight-month low amid economic strains, hawkish fed
Upbeat economic data in the US, along with the Fed’s hawkish rhetoric, a headwind for the Euro. Read Full Story at source (may require regi...
September 27, 2023, 9:59 pm
Out west, businesses are taking out more loans despite recession fears
Credit unions and banks are lending more to merchants based in the Western U.S., reflecting trends reported in the Umpqua Bank 2023 Business Barometer...
September 27, 2023, 9:44 pm
Usd/cad slipping back beneath 1.3500 as surging oil prices boost cad
The USD/CAD kicked Wednesday off with a jump to 1.3543 as the US Dollar (USD) caught a broad-market bid on risk aversion and bumper US data, but soari...
September 27, 2023, 9:44 pm
Audusd found sellers after elliott wave double three pattern [video]
AUDUSD made proposed leg up and complete 7 swings structure. Previous high: 0.65207 held well during the correction. The pair found sellers at the ext...
September 27, 2023, 9:44 pm
Dollar outlook: usd is overbought and looks vulnerable to declines – markets insider
The US dollar has climbed over recent weeks but with could see weakness ahead of the Federal Reserve’s June policy meeting, according to an FxPro st...
September 27, 2023, 9:44 pm
Tsx’s decline since mid-month hits 5.75% as gold slides
Canada’s main stock index fell on Wednesday to its lowest closing level in more than three months as bond yields continued to climb and a drop in go...
September 27, 2023, 9:29 pm
Lululemon athletica: demonstrating resilience through innovation
Lululemon Athletica's Q2 highlights include an 18% YoY increase in revenue and diluted EPS and raised FY23 guidance. The company's ability to innovate...
September 27, 2023, 9:13 pm
Us dollar price action: eur/usd, gold, gbp/usd, usd/cad, usd/jpy
The US Dollar rally has continued to another fresh 2023 high. Price crossed the 105.88 level on Monday and the bullish trend has seemed to hasten sinc...
September 27, 2023, 8:59 pm
Target for the correction in equities is still the 200-day moving average
Summary When I drew the neckline on an obviously forming head-and shoulders top here a week ago, I did not know for sure that we would close below the...
September 27, 2023, 8:44 pm
Thor equities sells upper east side townhouse after 11 years
Thor Equities sold an Upper East Side townhouse 11 years after listing the commercial property at 60 East 66th Street. Read Full Story at source (may ...
September 27, 2023, 8:44 pm
S&p 500 posts late recovery as gold melts below $1900, where to next?
Form a technical perspective, Gold prices recorded its worst day since July, falling around $30 on the day. As discussed yesterday we have now seen a ...
September 27, 2023, 8:44 pm
Which gold investment type is best for seniors?
Investing in gold stocks, like gold mining stocks, can be a viable option for seniors looking for potential growth and dividend income in their portfo...
September 27, 2023, 8:44 pm
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...
September 27, 2023, 8:05 pm
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...
September 27, 2023, 8:05 pm
Nzd/usd faces headwinds amid souring market sentiment, hawkish fed stance
The New Zealand Dollar (NZD) lost ground versus the US Dollar (USD) late in the New York session after hitting a daily high of 0.5956 but erased those...
September 27, 2023, 7:59 pm
Gold price forecast: xau/usd collapses below $1,900 as fears back the usd
XAU/UD pressures fresh multi-week lows and aims to extend its slump in the near term. Read Full Story at source (may require regi...
September 27, 2023, 7:44 pm
Fda panel rejects als treatment from brainstorm cell therapeutics
A U.S. Food and Drug Administration advisory committee voted against a treatment from BrainStorm Cell T...
September 27, 2023, 7:36 pm